LNTH · Nasdaq · CIK 0001521036
Lantheus Holdings, Inc.
Lantheus Holdings, Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 22, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.5B and net income of $233.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 30 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Lantheus Holdings, Inc.
- Ticker
- LNTH
- SEC Central Index Key (CIK)
- 0001521036
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances (code 2835)
- Business address
- BEDFORD, MA
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #1149 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Lantheus Holdings, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $425.2M | $935.1M | $1.3B | $1.5B | $1.5B |
| Net income | -$71.3M | $28.1M | $326.7M | $312.4M | $233.6M |
| Diluted EPS | -$1.06 | $0.40 | $4.65 | $4.36 | $3.41 |
| Total assets | $863.8M | $1.3B | $1.7B | $2.0B | $2.2B |
| Cash and equivalents | $98.5M | $415.7M | $713.7M | $912.8M | $359.1M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 26, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Oct 22, 2026 | 8-K | Other events· period Oct 21, 2026 | Document · Index |
| Mar 20, 2026 | DEF 14A | Definitive proxy statement· period Apr 30, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Lantheus Holdings, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 22, 2026 | 8-K | Other events· period Oct 21, 2026 | Document · Index |
| Oct 14, 2026 | 8-K | Shareholder vote results· period Oct 14, 2026 | Document · Index |
| Oct 2, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Oct 2, 2026 | 8-K | Other events· period Oct 2, 2026 | Document · Index |
| Sep 23, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Sep 21, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Sep 21, 2026 | 8-K | Other events· period Sep 17, 2026 | Document · Index |
| Sep 17, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Sep 8, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Sep 3, 2026 | Document · Index |
| Sep 8, 2026 | DEFM14A | DEFM14A | Document · Index |
| Sep 4, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Sep 2, 2026 | Document · Index |
| Sep 4, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Sep 4, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Sep 4, 2026 | SCHEDULE 13D | Active beneficial ownership report (over 5%) | Document · Index |
| Sep 3, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Sep 1, 2026 | Document · Index |
| Sep 2, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 31, 2026 | Document · Index |
| Sep 2, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 31, 2026 | Document · Index |
| Sep 2, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| Aug 26, 2026 | PREM14A | PREM14A· period Aug 26, 2026 | Document · Index |
| Aug 19, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026 | Document · Index |
| Aug 19, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026 | Document · Index |
| Aug 13, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Aug 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Results of operations· period Aug 6, 2026 | Document · Index |
| Aug 4, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Aug 4, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Aug 4, 2026 | 8-K | Material agreement; Director or officer change· period Aug 1, 2026 | Document · Index |
| Aug 3, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Aug 3, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Aug 3, 2026 | 8-K | Regulation FD disclosure; Other events· period Aug 3, 2026 | Document · Index |
| Jul 31, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Jun 3, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| Jun 3, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| May 29, 2026 | SD | Specialized disclosure report (conflict minerals) | Document · Index |
| May 18, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| May 18, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| May 18, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| May 18, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
| May 18, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 14, 2026 | Document · Index |
Insider filing activity
30 Form 4 filings appear in Lantheus Holdings, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in In Vitro & In Vivo Diagnostic Substances
- IDXX IDEXX LABORATORIES INC /DE
- NEOG NEOGEN CORP
- CLDX Celldex Therapeutics, Inc.
- NTLA Intellia Therapeutics, Inc.
- QDEL QuidelOrtho Corp
- ACHV ACHIEVE LIFE SCIENCES, INC.
- MYGN MYRIAD GENETICS INC
All 8 companies in In Vitro & In Vivo Diagnostic Substances· Companies headquartered in Massachusetts
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001521036 and XBRL company facts. Lantheus Holdings, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement